亚临床炎症关节组织消退或进展为类风湿关节炎的自然顺序:TREAT EARLIER 试验系列 MRI 研究
研究基于 TREAT EARLIER 试验安慰剂组 185 次系列 MRI,分析临床疑似关节痛患者亚临床关节炎症的自然演变。进展为类风湿关节炎者滑膜炎、腱鞘炎和骨炎同时增加,骨炎在诊断前最后 4 个月增加,此前 1 年至 4 个月已有腱鞘炎和滑膜炎变化。疼痛自发缓解者三种炎症同时减轻,腱鞘炎在起病后前 4 个月先减轻。
要点
- 进展为类风湿关节炎者滑膜炎、腱鞘炎和骨炎同时增加,骨炎在诊断前最后 4 个月增加。
- 抗环瓜氨酸蛋白抗体阳性和阴性进展者均在类风湿关节炎发生前出现骨炎增加。
- 疼痛缓解者腱鞘炎在起病后前 4 个月先减轻,滑膜炎和骨炎在 4 至 12 个月减轻。
核心结论
- 研究识别出不同关节组织亚临床炎症的自然顺序,加深了对临床关节炎和类风湿关节炎发展的理解。
- 类风湿关节炎进展过程中,骨炎增加紧随此前腱鞘炎和滑膜炎的增加。
- 疼痛缓解过程中,腱鞘炎先减轻,随后滑膜炎和骨炎减轻。
研究设计与样本
- 研究分析 TREAT EARLIER 试验安慰剂组中伴亚临床关节炎症的临床疑似关节痛患者的 185 次系列磁共振图像。
- 21 例进展为类风湿关节炎者共 52 次磁共振图像,分别在类风湿关节炎发生前 1 年、前 4 个月及发生时进行。
- 35 例疼痛自发缓解者共 133 次磁共振图像,分别在基线及第 4、12、24 个月进行。
- 磁共振图像对骨炎、滑膜炎和腱鞘炎进行评分,采用交叉滞后模型评估组织间炎症变化的时间模式。
主要发现
- 进展为类风湿关节炎者滑膜炎、腱鞘炎和骨炎同时增加。
- 骨炎增加发生在类风湿关节炎诊断前最后 4 个月,此前 1 年至 4 个月已有腱鞘炎和滑膜炎的递增变化(P < 0.01)。
- 抗环瓜氨酸蛋白抗体阳性和阴性进展为类风湿关节炎者均在类风湿关节炎发生前出现骨炎增加。
- 疼痛缓解者滑膜炎、腱鞘炎和骨炎同时减轻,腱鞘炎在临床疑似关节痛起病后前 4 个月先减轻,滑膜炎和骨炎在 4 至 12 个月减轻(P = 0.02 和 P < 0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The natural trajectory of clinical arthritis progression at the tissue level remains elusive. We hypothesized that subclinical inflammation in different joint tissues (synovitis, tenosynovitis, osteitis) increases in a distinct temporal order in patients with clinically suspect arthralgia (CSA) who develop rheumatoid arthritis (RA) and subsides in a different sequence when CSA spontaneously resolves. METHODS: We studied 185 serial magnetic resonance images (MRIs) from CSA patients with subclinical joint inflammation from the placebo arm of the TREAT EARLIER trial: 52 MRIs from 21 RA progressors (MRIs conducted at 1 year before, at 4 months before, and upon RA development), and 133 MRIs from 35 patients with spontaneous resolution of pain (MRIs conducted at baseline and at 4, 12, and 24 months). MRIs were scored for osteitis, synovitis, and tenosynovitis. We used cross-lagged models to evaluate 2 types of time patterns between pairs of inflamed tissues: a simultaneous pattern (coinciding changes) and a subsequent pattern (inflammatory changes in 1 tissue preceding changes in another tissue). RESULTS: In patients who developed RA, synovitis, tenosynovitis, and osteitis increased simultaneously. Increasing osteitis occurred in the final 4 months before RA diagnosis, following incremental tenosynovitis and synovitis changes during the 1 year to 4 months before diagnosis (P < 0.01). In anti-citrullinated protein antibody (ACPA)-positive and ACPA-negative patients who progressed to RA, osteitis increased just before RA development. In patients with pain resolution, simultaneous decreases in synovitis, tenosynovitis, and osteitis occurred, with tenosynovitis decreasing in the first 4 months after CSA onset preceding decreasing synovitis and osteitis during 4-12 months (P = 0.02 and P < 0.01). CONCLUSION: We identified natural sequences of subclinical inflammation in different joint tissues, which deepens our understanding of clinical arthritis and RA development. During RA progression, increasing osteitis followed previous increases in tenosynovitis and synovitis. During pain resolution, tenosynovitis decreased first, followed by decreasing synovitis and osteitis.
引用
- Krijbolder DI, Matthijssen XME, van Dijk BT, et al. The Natural Sequence in Which Subclinical Inflamed Joint Tissues Subside or Progress to Rheumatoid Arthritis: A Study of Serial MRIs in the TREAT EARLIER Trial. Arthritis Rheumatol. 2023. PMID: 37094363. doi:10.1002/art.42527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。